Dr. Ali Youssef Fakhreddine, MD

Dr. Fakhreddine practices at Scripps Clinic in Encinitas, California.

Dr. Fakhreddine's NPI, 1336586908, was assigned on May 22, 2013. Dr. Fakhreddine graduated from UT Southwestern Medical Center in 2013. Dr. Fakhreddine holds California license A133244.

Dr. Fakhreddine's primary practice is Scripps Clinic, at 326 Santa Fe Dr, Encinitas, CA 92024 in San Diego County. The practice phone is (858) 554-9100.

Dr. Fakhreddine's primary practice is Scripps Clinic in Encinitas, California. Dr. Fakhreddine is also affiliated with Scripps Memorial Hospital Encinitas. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Fakhreddine to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fakhreddine practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Fakhreddine's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Fakhreddine is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Fakhreddine is licensed in California.

Dmand AI lists acid reflux, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, intestinal diverticulosis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Fakhreddine treats.

CMS data shows 1,039 Medicare services from Dr. Fakhreddine across 13 procedure codes in 2024, for 403 Medicare patients. Medicare paid $80,902 for them.

CMS counts 403 Medicare patients who saw Dr. Fakhreddine in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fakhreddine's median patient age at 57, with 54% women.

In 2024, Dr. Fakhreddine wrote 595 Medicare Part D claims for 234 patients. 81% of them were for generic drugs. CMS names the drug for 495 of them, across 11 drugs with 11 or more claims each, at $83,193 in total drug cost. In 2023, CMS named 559 claims across 13 drugs.

Dr. Fakhreddine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fakhreddine as offering telehealth. CMS counts 123 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Fakhreddine, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Fakhreddine, published from 2019 to 2023. 2020 was the busiest year, with 2. Dr. Fakhreddine's most frequent co-authors are Catherine Therese Frenette, MD, Ken Fujioka, MD and Gauree Gupta Konijeti, MD, MPH.

CMS Open Payments shows 165 general payments to Dr. Fakhreddine from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $1,118.

Dr. Fakhreddine graduated from UT Southwestern Medical Center in 2013.

Dr. Fakhreddine is in network with 5 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.